Nuveen
SNTI icon

Nuveen’s Senti Biosciences Holdings SNTI Stock Holding History

Nuveen’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.02K Buy
+9,819
New +$4.53K ﹤0.01% 4775

Other funds holding SNTI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Menlo Ventures Management
Menlo Ventures Management Menlo Park, California $241M AUM
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Nuveen's SNTI Position: Q3 2026 in Review

Nuveen opened a new position in Senti Biosciences Holdings (SNTI) in Q3 2026: 9,819 shares worth $3.02K. The stake represents ﹤0.01% of the portfolio and ranks #4775 among its holdings.

6 funds tracked by Wall St. Rank hold SNTI as of Q3 2026.

  • Nuveen held 9,819 shares of Senti Biosciences Holdings worth $3.02K as of Q3 2026.
  • Senti Biosciences Holdings was a new Nuveen position in Q3 2026.
  • Senti Biosciences Holdings made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4775 holding.
  • 6 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.